Open Access Medical Education
Committed to sharing Internal Medicine focused lectures as free open access medical education.
Dr. Forest Arnold returns to discuss co-infections in COVID-19 by first presenting case reports and pathophysiology. After, he explains etiology and frequency and finally, diagnosis and treatment.
Read MoreDr. Forest Arnold returns to present "COVID-19 Vaccines: Wows and Woes" today on Louisville Lectures. In this presentation, Dr. Arnold gives an overview of COVID-19 and vaccines. He then discusses a case of potential thrombosis due to the Johnson & Johnson vaccine as well as the pathophysiology of vaccine-induced immune thrombotic thrombocytopenia (VITT). After, he presents the CDC Advisory Committee on Immunization Practices and the efficacy of vaccines in light of variants. And finally, Dr. Arnold discusses post acute COVID-19 Syndrome (PACS).
Read MoreDr. Mark Burns gives an update on COVID-19 by first discussing its history and epidemiology. He then describes the lifecycle of Sars-CoV-2 and the events surrounding the Cytokine Storm. After, he explains the clinical presentation and current commendations for pharmacologic management and finally, the vaccines in phase 3 trials.
Read MoreLouisville Lectures wishes everyone a safe holiday season! Stay #healthyathome and follow CDC guidelines for how to protect you and your loved ones.
Read MoreDr. Laura Bishop presents part two of the the COVID-19 Series where she discusses the natural course of disease. She covers practical aspects of evaluating and triaging patients including appropriate personal protective equipment (PPE) usage and finishes this segment with clinical exam/laboratory/imaging findings.
Read MoreDr. Laura Bishop presents the COVID-19 Series. In part one, she discusses the background of COVID-19 from virology, to epidemiology and symptoms. Stay tuned for Part Two when she discusses clinical care.
Read MoreDr. Forest Arnold's focuses on summarizing the extent of human coronaviruses, risk factors, and the clinical presentation of patients with coronavirus to the extent known. He then identifies the current infection prevention and control approach, as well as clinical management and future directions.
Read More